Research centre
1201 9th Ave, United States
Type 1 Diabetes TrialNet
Research centre · 1201 9th Ave, United States
Who this is for
- Prediabetes
- Type 1
Overview
International T1D research network offering free risk screening for relatives and clinical trials to prevent or delay type 1 diabetes.
About
TrialNet is an international network of leading academic institutions, endocrinologists, physicians, scientists and healthcare teams dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis. Funded primarily by the US National Institutes of Health (Special Statutory Funding Program for Type 1 Diabetes), with support from Breakthrough T1D (formerly JDRF) and the American Diabetes Association. What we offer: - Pathway to Prevention: free risk screening for eligible relatives of people with T1D (ages 2-45 in the US and Canada) - Prevention studies for people at elevated risk - Newly diagnosed studies to slow progression and preserve beta cell function There are 200+ screening and study locations across the US and worldwide. Find your nearest site at trialnet.org/locations. Contact: 1-800-425-8361 (Mon-Fri, 8am-5pm ET) or info@trialnet.org
Opening hours
| Monday | 08:00–17:00 |
|---|---|
| Tuesday | 08:00–17:00 |
| Wednesday | 08:00–17:00 |
| Thursday | 08:00–17:00 |
| Friday | 08:00–17:00 |
| Saturday | Closed |
| Sunday | Closed |
What we do
- T1D risk screening (Pathway to Prevention)
- Free screening for eligible relatives
- Autoantibody testing
- Prevention clinical trials
- Newly diagnosed clinical trials
- Beta cell preservation research
- Clinical study participation
- Family member screening programme
- T1D staging education
- Research study referrals
- At-home screening kits (US)
- Lab-based screening (Quest / LabCorp)
- International clinical trial network
- 200+ screening and study locations
- Researcher and clinician resources
- NIH-funded T1D prevention research
Location
1201 9th Ave, 1201 9th Ave Seattle, United States
